{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T01:04:44Z","timestamp":1783731884213,"version":"3.55.0"},"reference-count":43,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2025,2,13]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:sec>\n            <jats:title\/>\n            <jats:p>\n              This comparative study aimed at qualifying a broth microdilution (BMD) assay for phenotypic drug susceptibility testing (pDST) of\n              <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n              complex (MTBC) strains for implementation in a routine DST workflow. The assay was developed based on the EUCAST (European Committee on Antimicrobial Susceptibility Testing) reference protocol for determination of the minimum inhibitory concentration (MIC) of 14 anti-tuberculous drugs (isoniazid [INH], rifampicin [RIF], ethambutol [EMB], amikacin [AMI], moxifloxacin [MFX], levofloxacin [LFX], bedaquiline [BDQ], clofazimine [CFZ], delamanid [DLM], pretomanid [PA], para-aminosalicylic acid [PAS], linezolid [LZD], ethionamide [ETH], and cycloserine [CS]). Forty MTBC strains with various drug resistance profiles were tested to determine the agreement between MIC results and genotypic drug susceptibility testing (gDST) results derived from whole-genome sequencing (WGS). The agreement between the BMD and gDST results was solid for the majority of the drugs (average agreement 98%, range 90%\u2013100%), including key drugs such as INH, RIF, MFX, LFX, BDQ, DLM, and PA. Ten discrepancies were identified (corresponding to 1.8% of the total number of MIC determinations) and most (8\/10) were characterized by MICs equal or close to the potential critical concentration (pCC) applied in the BMD assay. Importantly, the assay can be adjusted to new drug recommendations and concentrations, tailored to local needs. We conclude that the BMD assay provides reliable results, and its implementation in our MTBC routine workflow will produce valuable data that improve our understanding and management of MTBC drug resistance.\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1128\/aac.00946-24","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T14:00:24Z","timestamp":1734530424000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":14,"title":["Performance of a broth microdilution assay for routine minimum inhibitory concentration determination of 14 anti-tuberculous drugs against the\n            <i>Mycobacterium tuberculosis<\/i>\n            complex based on the EUCAST reference protocol"],"prefix":"10.1128","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9289-351X","authenticated-orcid":true,"given":"Mikael","family":"Mansj\u00f6","sequence":"first","affiliation":[{"name":"Public Health Agency of Sweden","place":["Solna, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9536-0548","authenticated-orcid":false,"given":"Carmen","family":"Espinosa-Gongora","sequence":"additional","affiliation":[{"name":"Public Health Agency of Sweden","place":["Solna, Sweden"]},{"name":"ECDC Fellowship Programme, Public Health Microbiology path (EUPHEM), European Centre for Disease Prevention and Control (ECDC)","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishak","family":"Samanci","sequence":"additional","affiliation":[{"name":"Public Health Agency of Sweden","place":["Solna, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2696-437X","authenticated-orcid":false,"given":"Ramona","family":"Groenheit","sequence":"additional","affiliation":[{"name":"Public Health Agency of Sweden","place":["Solna, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2500-9792","authenticated-orcid":false,"given":"Jim","family":"Werngren","sequence":"additional","affiliation":[{"name":"Public Health Agency of Sweden","place":["Solna, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(22)00116-1"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab359"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01550-17"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244829"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00344-18"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-023899"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2016.10.022"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.07.037"},{"key":"e_1_3_3_10_2","first-page":"565","article-title":"Mycobacteria: laboratory methods for testing drug sensitivity and resistance","volume":"29","author":"Canetti G","year":"1963","unstructured":"Canetti G, Froman S, Grosset J, Hauduroy P, Langerova M, Mahler HT, Meissner G, Mitchison DA, Sula L. 1963. Mycobacteria: laboratory methods for testing drug sensitivity and resistance. Bull World Health Organ 29:565\u2013578.","journal-title":"Bull World Health Organ"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.07.036"},{"key":"e_1_3_3_12_2","unstructured":"European Committee on Antimicrobial Susceptibility Testing. 2019. MIC distributions and epidemiological cut-off value (ECOFF) setting EUCAST SOP 10.1. http:\/\/www.eucast.org."},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv145"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00239-2022"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02259-2022"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02397-2022"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00426-2023"},{"key":"e_1_3_3_18_2","unstructured":"WHO. 2018. Technical report on critical concentrations for drug susceptibility testing of medicines used in the treatment of drug-resistant tuberculosis."},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00025-15"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-019-0650-x"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(15)00466-X"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz215"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2023.102380"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11071809"},{"key":"e_1_3_3_25_2","unstructured":"Folkh\u00e4lsomyndigheten. Tuberculosis - disease statistics. Folkh\u00e4lsomyndigheten. Available from: https:\/\/www.folkhalsomyndigheten.se\/folkhalsorapportering-statistik\/statistik-a-o\/sjukdomsstatistik\/tuberkulos\/?year%5B%5D=&scope%5B%5D=all&tab=tab-region"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5812"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01026-22"},{"key":"e_1_3_3_28_2","volume-title":"Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance","author":"WHO","unstructured":"WHO. Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance"},{"key":"e_1_3_3_29_2","unstructured":"R Core Team. 2013. R: a language and environment for statistical computing. Foundation for statistical computing. Vienna Austria. https:\/\/www.R-project.org."},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.21105\/joss.01686"},{"key":"e_1_3_3_31_2","unstructured":"Stevenson M Sergeant E Firestone S. 2023. epiR: tools for the analysis of epidemiological data. https:\/\/CRAN.R-project.org\/package=epiR."},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043467"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1159\/000052378"},{"key":"e_1_3_3_34_2","volume-title":"ISBN: 9789240090491WHO operational handbook on tuberculosis: module 3: diagnosis: rapid diagnostics for tuberculosis detection: web annex B: critical concentrations for pretomanid and cycloserine: WHO policy statement","author":"World Health Organization","unstructured":"World Health Organization. ISBN: 9789240090491. WHO operational handbook on tuberculosis: module 3: diagnosis: rapid diagnostics for tuberculosis detection: web annex B: critical concentrations for pretomanid and cycloserine: WHO policy statement. 3rd ed","edition":"3"},{"key":"e_1_3_3_35_2","volume-title":"ISBN: 9789240082410Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance","author":"WHO","year":"2023","unstructured":"WHO. 2023. ISBN: 9789240082410. Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance. 2nd ed","edition":"2"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01302-08"},{"key":"e_1_3_3_37_2","unstructured":"European Committee on Antimicrobial Susceptibility Testing. 2021. EUCAST reading guide for broth microdilution. Version 3.0. http:\/\/www.eucast.org."},{"key":"e_1_3_3_38_2","volume-title":"ISBN: 978-92-4-004741-9Optimized broth microdilution plate methodology for drug susceptibility testing of Mycobacterium tuberculosis complex","author":"WHO","year":"2022","unstructured":"WHO. 2022. ISBN: 978-92-4-004741-9. Optimized broth microdilution plate methodology for drug susceptibility testing of Mycobacterium tuberculosis complex"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.2003.03425.x"},{"key":"e_1_3_3_40_2","unstructured":"European Committee on Antimicrobial Susceptibility Testing. 2019. Area of Technical Uncertainty (ATU) in antimicrobial susceptibility testing"},{"key":"e_1_3_3_41_2","volume-title":"CLSI supplement M62Performance standards for susceptibility testing of mycobacteria, Nocardia spp., and other aerobic actinomycetes","author":"Clinical and Laboratory Standards Institute","year":"2018","unstructured":"Clinical and Laboratory Standards Institute. 2018. CLSI supplement M62. Performance standards for susceptibility testing of mycobacteria, Nocardia spp., and other aerobic actinomycetes. 1st ed","edition":"1"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkac070"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00070-24"},{"key":"e_1_3_3_44_2","unstructured":"European Committee on Antimicrobial Susceptibility Testing. 2021. MIC distributions and epidemiological cut-off value (ECOFF) setting EUCAST SOP 10.2. Available from: http:\/\/www.eucast.org"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.00946-24","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.00946-24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T15:06:48Z","timestamp":1739459208000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/aac.00946-24"}},"subtitle":[],"editor":[{"given":"Sean","family":"Wasserman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2,13]]}},"alternative-id":["10.1128\/aac.00946-24"],"URL":"https:\/\/doi.org\/10.1128\/aac.00946-24","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,13]]},"assertion":[{"value":"2024-06-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00946-24"}}